SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chiroscience

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Reynolds who wrote (20)2/15/1998 8:59:00 AM
From: UPAL  Read Replies (1) of 69
 
James...Thankyou for informative posts...you are in my People Mark section.
"Investors are much more cautious and even great news like Chiroscience's Bristol Myers Squibb deal is getting a muted response
from the stock market. However, later in 98 there is the possibility of product approvals for Chiroscience (Chirocaine) and Cortecs (Macritonin) which would be an enormous boost for the sector"

May be institutions are accumulating now in order to unload when this
sector in UK gets hot, Assuming Phase 1,11 & 111 approvals happen in time, above mentioned stocks should take off. Potential is there..??

I plan to average down on Chiroscience. Any thoughts on CNTBY and BBIOY, additional phase 111 trials needed by BBIOY is only a minor set back...IMHO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext